EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Sarcopenic obesity in liver disease: Handling both sides of the penny

Yangyang Hui, Binxin Cui, Xiaoyu Wang, Mingyu Sun, Yifan Li, Wanting Yang, Gaoyue Guo, Lihong Mao, Zihan Yu, Xiaofei Fan, Chao Sun

Portal Hypertension & Cirrhosis · 2022

DOI: 10.1002/poh2.10 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Portal Hypertension & Cirrhosis, 2022. Verfasst von Yangyang Hui und 10 weiteren Autor:innen. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 135 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Skeletal muscle and fat tissue show distinct pathophysiological roles and pivotal functions. The culmination of muscle wasting and fat accumulation represents an opposite terminal of each state. Specifically, this situation has been designated as sarcopenic obesity. However, sarcopenic obesity still lacks a unanimous definition, diagnostic criteria, and generalized modalities for assessment in the context of versatile liver diseases. Moreover, the underpinning mechanisms by which a combination of abnormal skeletal muscle and fat tissue leads to the progression of liver disease and impairs health‐related consequences are still elusive. Additionally, the interplay between skeletal muscle and fat, and the driving factors that shift different body compositions are not well understood. Therefore, in this review, we discuss skeletal muscle and fat components, with the purpose of conceptualization, as well as interpret their roles in liver diseases. We focus on the definitions, diagnostic criteria, and currently available measurements for sarcopenic obesity in the literature. We comprehensively discuss recent data and evidence regarding the potential role of sarcopenic obesity in the development and progression of numerous liver diseases and associated conditions, including nonalcoholic fatty liver disease, chronic viral hepatitis, cirrhosis, and liver transplantation. Furthermore, explicit information related to the pathogenesis of sarcopenic obesity from basic research is also provided in this narrative review. Finally, we discuss, from the clinical perspective of view, how to manage sarcopenic obesity using nutritional, physical, and pharmacological methods.

Zitieren

APA

Hui, Y., Cui, B., Wang, X., Sun, M., Li, Y., Yang, W., Guo, G., Mao, L., Yu, Z., Fan, X., & Sun, C. (2022). Sarcopenic obesity in liver disease: Handling both sides of the penny. Portal Hypertension & Cirrhosis. https://doi.org/10.1002/poh2.10

Vancouver

Hui Y, Cui B, Wang X, Sun M, Li Y, Yang W, et al. Sarcopenic obesity in liver disease: Handling both sides of the penny. Portal Hypertension & Cirrhosis. 2022. doi:10.1002/poh2.10

BibTeX
@article{Hui2022,
  author = {Hui, Yangyang and Cui, Binxin and Wang, Xiaoyu and Sun, Mingyu and Li, Yifan and Yang, Wanting and Guo, Gaoyue and Mao, Lihong and Yu, Zihan and Fan, Xiaofei and Sun, Chao},
  title = {Sarcopenic obesity in liver disease: Handling both sides of the penny},
  journal = {Portal Hypertension & Cirrhosis},
  year = {2022},
  doi = {10.1002/poh2.10}
}
Kostenlos starten →